Ankyrin G Overexpression in Hutchinson-Gilford Progeria Syndrome fibroblasts Identified Through Biological filtering of Expression Profiles

Total Page:16

File Type:pdf, Size:1020Kb

Ankyrin G Overexpression in Hutchinson-Gilford Progeria Syndrome fibroblasts Identified Through Biological filtering of Expression Profiles J Hum Genet (2006) 51:934–942 DOI 10.1007/s10038-006-0042-0 ORIGINAL ARTICLE Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles Jian Wang Æ John F. Robinson Æ Caroline H. O’Neil Æ Jane Y. Edwards Æ Christina M. Williams Æ Murray W. Huff Æ J. Geoffrey Pickering Æ Robert A. Hegele Received: 5 March 2006 / Accepted: 23 July 2006 / Published online: 11 October 2006 Ó The Japan Society of Human Genetics and Springer-Verlag 2006 Abstract Hutchinson-Gilford progeria syndrome in culture, including increased expression of ANK3/ (HGPS; MIM 176670) is a rare disease characterized ankyrin G. Furthermore, other genes that co-clustered by accelerated aging. In this study, light and immuno- with ANK3 might provide mechanistic clues regarding fluorescence microscopy were used to assess morpho- senescence in cultured HGPS cells. logical changes, measures of cell growth kinetics and gene expression profiles in HGPS cells and normal fi- Keywords RNA microarrays Á Bioinformatics Á broblasts in culture. A filtering strategy was developed Genomics Á Cytoskeleton Á Aging based on differentially expressed transcripts seen con- sistently across three culture stages based on cell pas- sage number. This filtering strategy produced a list of Introduction 66 unique differentially expressed genes, of which ~40% were upregulated in HGPS cells compared to Hutchinson-Gilford progeria syndrome (HGPS; MIM normal fibroblasts. The increased mRNA expression in 176670) is an extremely rare disease that is character- HGPS cells that was seen for one gene defined using ized by accelerated aging and early death (Pollex and this strategy—namely ANK3— was validated using Hegele 2004). Organ systems degenerate to such an quantitative reverse-transcriptase amplification, Wes- extent that the affected subject resembles an old per- tern analysis and immunofluorescence microscopy, all son. Clinical features include short stature, microgna- of which showed significantly increased ankyrin G thia, alopecia, prominent scalp veins, prominent joints, expression. These findings demonstrate differences in hyperlipidemia and atherosclerosis, often with pre- morphology, growth kinetics and mRNA expression mature death from coronary artery disease. The ge- profiles in HGPS cells compared to normal fibroblasts netic basis for >90% of cases of HGPS is a de novo recurrent c.2036C>T splicing mutation in LMNA, encoding nuclear lamin A/C, although there is some J. Wang Á J. F. Robinson Á C. H. O’Neil Á J. Y. Edwards Á heterogeneity of mutations (Eriksson et al. 2003;De C. M. Williams Á M. W. Huff Á J. G. Pickering Sandre-Giovannoli et al. 2003; Cao and Hegele 2003; Vascular Biology Research Group, Robarts Research Institute, 100 Perth Drive, Csoka et al. 2004a). London, ON, Canada N6A 5K8 In cultured HGPS fibroblasts, others have shown differential gene expression profiles, including changes R. A. Hegele (&) in expression of genes within the ontologies of tran- Vascular Biology Research Group, Robarts Research Institute, 406–100 Perth Drive, scription factors and extracellular matrix proteins London, ON, Canada N6A 5K8 compared to normal fibroblasts (Csoka et al. 2004b). e-mail: [email protected] Since the LMNA mutation is the primary insult within the germline of HGPS fibroblasts, changes in gene M. W. Huff Á J. G. Pickering Á R. A. Hegele Department of Medicine, University of Western Ontario, expression profiles are secondary and may provide London, ON, Canada clues about dysregulated pathways that lead to 123 J Hum Genet (2006) 51:934–942 935 abnormal phenotypes in cultured cells and perhaps and total RNA was then isolated using an RNeasy kit within intact tissues and organs. Our current objectives (Qiagen, Mississauga, ON). Isolated total RNA was were to: (1) develop a biological filtering approach to quantified by ultraviolet spectroscopy, and RNA characterize cellular and molecular differences be- integrity was evaluated using the BioAnalyzer 2100 tween cultured fibroblasts from a HGPS proband with Model G2938A (Agilent Technologies, Mississauga, the dominant LMNA c.2036C>T splicing mutation and ON). fibroblasts from a normal subject; and (2) validate this approach at the protein level using Western analysis Immunofluorescence studies and immunocytochemistry to study the product of a candidate gene that showed marked differential In order to determine proliferation differences be- mRNA expression. The filtering criteria included tween normal and HGPS fibroblasts, cells were grown opposite patterns of expression between HGPS and on coverslips to 80% confluence. Cells on coverslips normal fibroblasts at three different stages of cell cul- were washed twice with PBS, fixed with 4% parafor- ture maturity defined by passage number. maldehyde on ice for 20 min, and incubated with 0.5% Triton X-100 at room temperature for 5 min. Fixed cells were next incubated with a 1:150 dilution of Materials and methods monoclonal mouse anti-human Ki-67 antibody (Dako- Cytomation, Mississauga, ON) at 37°C in a humidified Cell culture chamber for 1 h, washed three times with PBS, then incubated with a 1:100 dilution of FITC goat anti- Human normal (AG04456) and HGPS (AG03513, mouse IgG (Cedarlane Laboratories, Hornby, ON) at LMNA mutation c.2036C>T) fibroblast cell lines were room temperature in a humidified chamber for 30 min. obtained from the Coriell Cell Repository (Camden, After washing three times with PBS, cells were stained NJ). Cells were grown in Dulbecco’s Modification of with Hoechst dye (2.5 lg/ml in PBS) (Sigma-Aldrich, Eagle’s Medium (DMEM), supplemented with 15% Oakville, ON) at room temperature for 5 min. Cells non-inactivated fetal bovine serum (FBS), at 37°Cin were then washed three times with PBS and mounted 5% CO2. Cells were passaged every 3 or 4 days and on glass slides using PermaFluor Aqueous Mounting seeded at a density of 2·105 per 90 mm diameter dish. Medium (Fisher, Markham, ON). Proliferating cells Cell growth curves were obtained by measuring accu- were identified by positive staining with the Ki-67 mulated population doublings (APD), using the for- antibody. mula (logH–logS)/log 2.0, where logH and logS are the In order to localize ankyrin G within fibroblasts, logarithms of the numbers of cells harvested and see- cultures grown on cover slips were fixed with 2% ded, respectively (Bridger and Kill 2004). paraformaldehyde at room temperature for 10 min, followed by incubation with 0.5% Triton X-100 at Genomic DNA isolation and direct sequencing room temperature for 2 min. Fixed cells were incu- bated with a 1:50 dilution of monoclonal mouse Genomic DNA was isolated from cultured cells using anti-human ankyrin G antibody (Santa Cruz Biotech- the Puregene kit (Gentra Systems, Minneapolis, MN). nology, Santa Cruz, CA) at 37°C in a humidified All coding exons, intron–exon boundaries and >300 bp chamber for 1 h, washed three times with PBS, then of 5¢ and 3¢ untranslated regions of the LMNA gene incubated with a 1:200 dilution of FITC goat anti- were amplified as described (Cao and Hegele 2003) mouse IgG at room temperature in a humidified and were then sequenced on a ABI 3730 DNA Ana- chamber for 30 min. After washing three times with lyzer (Applied Biosystems, Mississauga, ON). Muta- PBS, cells were stained with Hoechst dye (2.5 lg/ml in tions were identified using Sequence Navigator PBS) at room temperature for 5 min. Cells were then software (Applied Biosystems). washed three times with PBS and mounted on glass slides using PermaFluor Aqueous Mounting Medium Total RNA isolation (Fisher, Markham, ON). RNA was isolated at the elapsed cell culture ages of Microarray studies APD 2.5 (young), APD 10 (middle-aged) for both the normal and HGPS fibroblast cell lines; and at APD 26 Standard procedures of the London Regional Ge- (old) for the normal cell line and APD 17 (old) for the nomics Centre were used (Carter et al. 2005). Total HGPS fibroblasts. Cells were washed twice with PBS RNA isolates from three different cell ages—young, 123 936 J Hum Genet (2006) 51:934–942 middle, and old—of both normal and HGPS cell lines pre-processing (Irizarry et al. 2003), a summary measure were analyzed using the GeneChip Expression Array to normalize arrays that simultaneously adjusted back- HU133A (Affymetrix, Santa Clara, CA). A 25 ng ali- ground, normalized and log-transformed perfect match quot of total RNA from each sample was processed intensity values from the .cel files. A gene list was gen- using the GeneChip Expression 3¢-Amplification Re- erated with all Affymetrix technical quality assurance agents Two Cycle cDNA Synthesis Kit (Affymetrix, probes, marked using the ‘‘Affx’’ prefix. Santa Clara, CA). Sample quality was assessed using A compound filter was used to create the final gene the BioAnalyzer 2100 Model G2938A (Agilent Tech- list: (1) remove all ‘‘Affx’’ prefix genes; (2) remove all nologies) and degradation software as described intensity values £150 units in at least three out of six (Carter et al. 2005). Only samples that registered ‘‘no conditions; (3) remove all values £ 2-fold difference alert’’ were analyzed (Carter et al. 2005). A 600 ng between normal–young and HGPS–young expression sample of cRNA was used for the second cycle of values; and (4) filter on confidence of association with cDNA and cRNA synthesis. BIOTINYLATED frag- nominal P£0.1. This filter yielded a set of 66 unique mented cRNA (15 lg) was then hybridized onto genes that were up-regulated in normal and down- HU133A chips. GeneChips were washed and scanned regulated in the HGPS cell line and vice versa (Ta- on an Affymetrix Fluidics Module Model 400 and ble 1). A similar compound filter, with the exception of GeneChip Scanner Model 3000 controlled by Gene- not filtering on confidence, yielded a list of 462 genes Chip Operating System v1.3 (GCOS) (Affymetrix).
Recommended publications
  • Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth
    International Journal of Molecular Sciences Article Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth Daniel J. Owens 1,2 , Julien Messéant 1, Sophie Moog 3, Mark Viggars 2, Arnaud Ferry 1,4, Kamel Mamchaoui 1,5, Emmanuelle Lacène 5 , Norma Roméro 5,6, Astrid Brull 1 , Gisèle Bonne 1 , Gillian Butler-Browne 1 and Catherine Coirault 1,* 1 Center for Research in Myology, Sorbonne Université, INSERM UMRS_974, 75013 Paris, France; [email protected] (D.J.O.); [email protected] (J.M.); [email protected] (A.F.); [email protected] (K.M.); [email protected] (A.B.); [email protected] (G.B.); [email protected] (G.B.-B.) 2 Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool L3 3AF, UK; [email protected] 3 Inovarion, 75005 Paris, France; [email protected] 4 Université de Paris, 75006 Paris, France 5 Neuromuscular Morphology Unit, Institute of Myology, Pitié-Salpêtrière Hospital, 75013 Paris, France; [email protected] (E.L.); [email protected] (N.R.) 6 APHP, Reference Center for Neuromuscular Disorders, Pitié-Salpêtrière Hospital, Institute of Myology, 75013 Paris, France * Correspondence: [email protected]; Tel.: +33-1-1-4216-5708 Abstract: Laminopathies are a clinically heterogeneous group of disorders caused by mutations in the LMNA gene, which encodes the nuclear envelope proteins lamins A and C. The most frequent diseases associated with LMNA mutations are characterized by skeletal and cardiac involvement, and include autosomal dominant Emery–Dreifuss muscular dystrophy (EDMD), limb-girdle muscular Citation: Owens, D.J.; Messéant, J.; dystrophy type 1B, and LMNA-related congenital muscular dystrophy (LMNA-CMD).
    [Show full text]
  • ARVC-Variants.Pdf
    Updated gene list responsible for ARVC/D pathology Subtype Gene Location Reference ARVC1 TGFB3 14q24.3 Beffagna G, Occhi G, Nava A, et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65:366–73. ARVC2 RYR2 1q43 Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189–94. ARVC3 Unknown 14q12-q22 Severini GM, Krajinovic M, Pinamonti B, et al. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics. 1996;31:193–200. ARVC4 TTN 2q32.1-q32.3 Taylor M, Graw S, Sinagra G, et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation. 2011;124:876–85. ARVC5 TMEM43 3p25.1 Merner ND, Hodgkinson KA, Haywood AF, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 2008;82:809–21. ARVC6 Unknown 10p14-p12 Li D, Ahmad F, Gardner MJ, et al. The locus of a novel gene responsible for arrhythmogenic right- ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. Am J Hum Genet. 2000;66:148–56. ARVC7 DES 2q35 Klauke B, Kossmann S, Gaertner A, et al. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet. 2010;19:4595–607.
    [Show full text]
  • Genetic Mutations and Mechanisms in Dilated Cardiomyopathy
    Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, … , Jessica R. Golbus, Megan J. Puckelwartz J Clin Invest. 2013;123(1):19-26. https://doi.org/10.1172/JCI62862. Review Series Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of congestive heart failure. In hypertrophic cardiomyopathy (HCM), cardiac output is limited by the thickened myocardium through impaired filling and outflow. Mutations in the genes encoding the thick filament components myosin heavy chain and myosin binding protein C (MYH7 and MYBPC3) together explain 75% of inherited HCMs, leading to the observation that HCM is a disease of the sarcomere. Many mutations are “private” or rare variants, often unique to families. In contrast, dilated cardiomyopathy (DCM) is far more genetically heterogeneous, with mutations in genes encoding cytoskeletal, nucleoskeletal, mitochondrial, and calcium-handling proteins. DCM is characterized by enlarged ventricular dimensions and impaired systolic and diastolic function. Private mutations account for most DCMs, with few hotspots or recurring mutations. More than 50 single genes are linked to inherited DCM, including many genes that also link to HCM. Relatively few clinical clues guide the diagnosis of inherited DCM, but emerging evidence supports the use of genetic testing to identify those patients at risk for faster disease progression, congestive heart failure, and arrhythmia. Find the latest version: https://jci.me/62862/pdf Review series Genetic mutations and mechanisms in dilated cardiomyopathy Elizabeth M. McNally, Jessica R. Golbus, and Megan J. Puckelwartz Department of Human Genetics, University of Chicago, Chicago, Illinois, USA. Genetic mutations account for a significant percentage of cardiomyopathies, which are a leading cause of conges- tive heart failure.
    [Show full text]
  • Β-Catenin Confers Resistance to PI3K and AKT Inhibitors and Subverts Foxo3a to Promote Metastasis in Colon Cancer
    β-catenin Confers Resistance to PI3K and AKT inhibitors and Subverts FOXO3a to Promote Metastasis in Colon Cancer Stephan P. Tenbaum1§, Paloma Ordóñez-Morán2§#, Isabel Puig1§, Irene Chicote1, Oriol Arqués1, Stefania Landolfi3, Yolanda Fernández4, José Raúl Herance5, Juan D. Gispert5, Leire Mendizabal6, Susana Aguilar7, Santiago Ramón y Cajal3, Simó Schwartz Jr4, Ana Vivancos6, Eloy Espín8, Santiago Rojas5, José Baselga9, Josep Tabernero10, Alberto Muñoz2, Héctor G. Palmer1* 1 Vall d’Hebrón Institut d´Oncología (VHIO). Stem Cells and Cancer Laboratory. Barcelona, Spain. 2 Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain. 3 Department of Pathology, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain. 4 Group of Drug Delivery and Targeting, CIBBIM-Nanomedicine and Networking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital Universitari Vall d’Hebrón, Institut de Recerca Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain. 5 Parc de Recerca Biomèdica de Barcelona (PRBB), Centre d´Imatge Molecular (CRC) Corporació Sanitària, Barcelona, Spain. 6 Vall d’Hebrón Institut d´Oncología (VHIO). Genomics Cancer Group. Barcelona, Spain. 7 Centre for Respiratory Research, Rayne Institute, University College London, London, United Kingdom, Hematopoietic Stem Cell Laboratory, London Research Institute, Cancer Research UK, London, United Kingdom. 8 General Surgery Service, Hospital Universitari Vall d'Hebrón, Barcelona, Spain. 9 Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, USA; Howard Hughes Medical Institute, Chevy Chase, USA. 10 Medical Oncology Department, Hospital Universitari Vall d'Hebrón, Barcelona, Spain. # Swiss Institute for Experimental Cancer Research, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
    [Show full text]
  • Circular RNA Hsa Circ 0005114‑Mir‑142‑3P/Mir‑590‑5P‑ Adenomatous
    ONCOLOGY LETTERS 21: 58, 2021 Circular RNA hsa_circ_0005114‑miR‑142‑3p/miR‑590‑5p‑ adenomatous polyposis coli protein axis as a potential target for treatment of glioma BO WEI1*, LE WANG2* and JINGWEI ZHAO1 1Department of Neurosurgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033; 2Department of Ophthalmology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin 130021, P.R. China Received September 12, 2019; Accepted October 22, 2020 DOI: 10.3892/ol.2020.12320 Abstract. Glioma is the most common type of brain tumor APC expression with a good overall survival rate. UALCAN and is associated with a high mortality rate. Despite recent analysis using TCGA data of glioblastoma multiforme and the advances in treatment options, the overall prognosis in patients GSE25632 and GSE103229 microarray datasets showed that with glioma remains poor. Studies have suggested that circular hsa‑miR‑142‑3p/hsa‑miR‑590‑5p was upregulated and APC (circ)RNAs serve important roles in the development and was downregulated. Thus, hsa‑miR‑142‑3p/hsa‑miR‑590‑5p‑ progression of glioma and may have potential as therapeutic APC‑related circ/ceRNA axes may be important in glioma, targets. However, the expression profiles of circRNAs and their and hsa_circ_0005114 interacted with both of these miRNAs. functions in glioma have rarely been studied. The present study Functional analysis showed that hsa_circ_0005114 was aimed to screen differentially expressed circRNAs (DECs) involved in insulin secretion, while APC was associated with between glioma and normal brain tissues using sequencing the Wnt signaling pathway. In conclusion, hsa_circ_0005114‑ data collected from the Gene Expression Omnibus database miR‑142‑3p/miR‑590‑5p‑APC ceRNA axes may be potential (GSE86202 and GSE92322 datasets) and explain their mecha‑ targets for the treatment of glioma.
    [Show full text]
  • Nuclear Titin Interacts with A- and B-Type Lamins in Vitro and in Vivo
    Research Article 239 Nuclear Titin interacts with A- and B-type lamins in vitro and in vivo Michael S. Zastrow1,*, Denise B. Flaherty2‡, Guy M. Benian2 and Katherine L. Wilson1,§ 1Department of Cell Biology, The Johns Hopkins University School of Medicine, 725 N. Wolfe St, Baltimore, MD 21205, USA 2Department of Pathology, Emory University, Whitehead Biomedical Research Building, Atlanta, GA 30332, USA *Present address: Department of Developmental Biology, Stanford University School of Medicine, Beckman Center, B300, 279 Campus Drive, Stanford, CA 94305, USA ‡Department of Biology, Eckerd College, SHB 105, 4200 54th Ave, St Petersburg, FL 33711, USA §Author for correspondence (e-mail: [email protected]) Accepted 4 October 2005 Journal of Cell Science 119, 239-249 Published by The Company of Biologists 2006 doi:10.1242/jcs.02728 Summary Lamins form structural filaments in the nucleus. Mutations lamin-downregulated [lmn-1(RNAi)] embryos, Ce-titin was in A-type lamins cause muscular dystrophy, undetectable at the nuclear envelope suggesting its cardiomyopathy and other diseases, including progeroid localization or stability requires Ce-lamin. In human cells syndromes. To identify new binding partners for lamin A, (HeLa), antibodies against the titin-specific domain M-is6 we carried out a two-hybrid screen with a human skeletal- gave both diffuse and punctate intranuclear staining by muscle cDNA library, using the Ig-fold domain of lamin A indirect immunofluorescence, and recognized at least three as bait. The C-terminal region of titin was recovered twice. bands larger than 1 MDa in immunoblots of isolated HeLa Previous investigators showed that nuclear isoforms of titin nuclei.
    [Show full text]
  • Lamin A/C Cardiomyopathy: Implications for Treatment
    Current Cardiology Reports (2019) 21:160 https://doi.org/10.1007/s11886-019-1224-7 MYOCARDIAL DISEASE (A ABBATE AND G SINAGRA, SECTION EDITORS) Lamin A/C Cardiomyopathy: Implications for Treatment Suet Nee Chen1 & Orfeo Sbaizero1,2 & Matthew R. G. Taylor1 & Luisa Mestroni1 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review The purpose of this review is to provide an update on lamin A/C (LMNA)-related cardiomyopathy and discuss the current recommendations and progress in the management of this disease. LMNA-related cardiomyopathy, an inherited autosomal dominant disease, is one of the most common causes of dilated cardiomyopathy and is characterized by steady progression toward heart failure and high risks of arrhythmias and sudden cardiac death. Recent Findings We discuss recent advances in the understanding of the molecular mechanisms of the disease including altered cell biomechanics, which may represent novel therapeutic targets to advance the current management approach, which relies on standard heart failure recommendations. Future therapeutic approaches include repurposed molecularly directed drugs, siRNA- based gene silencing, and genome editing. Summary LMNA-related cardiomyopathy is the focus of active in vitro and in vivo research, which is expected to generate novel biomarkers and identify new therapeutic targets. LMNA-related cardiomyopathy trials are currently underway. Keywords Lamin A/C gene . Laminopathy . Heart failure . Arrhythmias . Mechanotransduction . P53 . CRISPR–Cas9 therapy Introduction functions, including maintaining nuclear structural integrity, regulating gene expression, mechanosensing, and Mutations in the lamin A/C gene (LMNA)causelaminopathies, mechanotransduction through the lamina-associated proteins a heterogeneous group of inherited disorders including muscu- [6–11].
    [Show full text]
  • ANK3 As a Risk Gene for Schizophrenia: New Data in Han Chinese And
    RESEARCH ARTICLE Neuropsychiatric Genetics ANK3 as a Risk Gene for Schizophrenia: New Data in Han Chinese and Meta Analysis Aihua Yuan,1 Zhenghui Yi,1 Qiang Wang,2 Jinhua Sun,1 Zhiqiang Li,3 Yasong Du,1 Chen Zhang,1 Tao Yu,3 Juan Fan,1 Huafang Li,1 and Shunying Yu1* 1Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China 2Mental Health Center Psychiatric Laboratory, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, P.R. China 3Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, P.R. China Manuscript Received: 13 December 2011; Manuscript Accepted: 4 October 2012 Histological and neuroimaging evidence supports the hypothesis that neuronal disconnectivity may be involved in the pathogenesis How to Cite this Article: of schizophrenia. A genome-wide association study (GWAS) Yuan A, Yi Z, Wang Q, Sun J, Li Z, Du Y, showed a single nucleotide polymorphism (SNP), rs10761482 in Zhang C, Yu T, Fan J, Li H, Yu S. 2012. ANK3 ANK3 ankyrin 3 ( ), a major neuron-enriched gene, was associated as a Risk Gene for Schizophrenia: New Data in with schizophrenia although inconsistent results had been Han Chinese and Meta Analysis. reported. Two meta analyses reported another SNP rs10994336 Am J Med Genet Part B 159B:997–1005. in ANK3 gene confers risk to bipolar disorder (BD). Due to evidence of genetic overlap between schizophrenia and BD, we investigated common findings by analyzing the association of ANK3 polymorphisms (rs10761482, rs10994336, and two mis- from family, adoption, and twins studies supported high herit- senses, rs3808942 and rs3808943) with schizophrenia, using the ability in the development of schizophrenia (80%).
    [Show full text]
  • Hippocampal LMNA Gene Expression Is Increased in Late-Stage Alzheimer’S Disease
    International Journal of Molecular Sciences Article Hippocampal LMNA Gene Expression is Increased in Late-Stage Alzheimer’s Disease Iván Méndez-López 1,2,*,†, Idoia Blanco-Luquin 1,†, Javier Sánchez-Ruiz de Gordoa 1,3, Amaya Urdánoz-Casado 1, Miren Roldán 1, Blanca Acha 1, Carmen Echavarri 1,4, Victoria Zelaya 5, Ivonne Jericó 3 and Maite Mendioroz 1,3,* 1 Neuroepigenetics Laboratory-Navarrabiomed, Complejo Hospitalario de Navarra, Universidad Pública de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra 31008, Spain; [email protected] (I.B.-L.); [email protected] (J.S.-R.d.G.); [email protected] (A.U.-C.); [email protected] (M.R.); [email protected] (B.A.); [email protected] (C.E.) 2 Department of Internal Medicine, Hospital García Orcoyen, Estella 31200, Spain 3 Department of Neurology, Complejo Hospitalario de Navarra- IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra 31008, Spain; [email protected] 4 Hospital Psicogeriátrico Josefina Arregui, Alsasua, Navarra 31800, Spain 5 Department of Pathology, Complejo Hospitalario de Navarra- IdiSNA (Navarra Institute for Health Research), Pamplona, Navarra 31008, Spain; [email protected] * Correspondence: [email protected] (I.M.-L.); [email protected] (M.M.); Tel.: +34-848-422677 (I.M.-L.) † These authors contributed equally to this work. Received: 30 November 2018; Accepted: 14 February 2019; Published: 18 February 2019 Abstract: Lamins are fibrillary proteins that are crucial in maintaining nuclear shape and function. Recently, B-type lamin dysfunction has been linked to tauopathies. However, the role of A-type lamin in neurodegeneration is still obscure.
    [Show full text]
  • HCC and Cancer Mutated Genes Summarized in the Literature Gene Symbol Gene Name References*
    HCC and cancer mutated genes summarized in the literature Gene symbol Gene name References* A2M Alpha-2-macroglobulin (4) ABL1 c-abl oncogene 1, receptor tyrosine kinase (4,5,22) ACBD7 Acyl-Coenzyme A binding domain containing 7 (23) ACTL6A Actin-like 6A (4,5) ACTL6B Actin-like 6B (4) ACVR1B Activin A receptor, type IB (21,22) ACVR2A Activin A receptor, type IIA (4,21) ADAM10 ADAM metallopeptidase domain 10 (5) ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 (4) ADCY2 Adenylate cyclase 2 (brain) (26) AJUBA Ajuba LIM protein (21) AKAP9 A kinase (PRKA) anchor protein (yotiao) 9 (4) Akt AKT serine/threonine kinase (28) AKT1 v-akt murine thymoma viral oncogene homolog 1 (5,21,22) AKT2 v-akt murine thymoma viral oncogene homolog 2 (4) ALB Albumin (4) ALK Anaplastic lymphoma receptor tyrosine kinase (22) AMPH Amphiphysin (24) ANK3 Ankyrin 3, node of Ranvier (ankyrin G) (4) ANKRD12 Ankyrin repeat domain 12 (4) ANO1 Anoctamin 1, calcium activated chloride channel (4) APC Adenomatous polyposis coli (4,5,21,22,25,28) APOB Apolipoprotein B [including Ag(x) antigen] (4) AR Androgen receptor (5,21-23) ARAP1 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (4) ARHGAP35 Rho GTPase activating protein 35 (21) ARID1A AT rich interactive domain 1A (SWI-like) (4,5,21,22,24,25,27,28) ARID1B AT rich interactive domain 1B (SWI1-like) (4,5,22) ARID2 AT rich interactive domain 2 (ARID, RFX-like) (4,5,22,24,25,27,28) ARID4A AT rich interactive domain 4A (RBP1-like) (28) ARID5B AT rich interactive domain 5B (MRF1-like) (21) ASPM Asp (abnormal
    [Show full text]
  • Nuclear Envelope Laminopathies: Evidence for Developmentally Inappropriate Nuclear Envelope-Chromatin Associations
    Nuclear Envelope Laminopathies: Evidence for Developmentally Inappropriate Nuclear Envelope-Chromatin Associations by Jelena Perovanovic M.S. in Molecular Biology and Physiology, September 2009, University of Belgrade M.Phil. in Molecular Medicine, August 2013, The George Washington University A Dissertation submitted to The Faculty of The Columbian College of Arts and Sciences of The George Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy August 31, 2015 Dissertation directed by Eric P. Hoffman Professor of Integrative Systems Biology The Columbian College of Arts and Sciences of The George Washington University certifies that Jelena Perovanovic has passed the Final Examination for the degree of Doctor of Philosophy as of May 5, 2015. This is the final and approved form of the dissertation. Nuclear Envelope Laminopathies: Evidence for Developmentally Inappropriate Nuclear Envelope-Chromatin Associations Jelena Perovanovic Dissertation Research Committee: Eric P. Hoffman, Professor of Integrative Systems Biology, Dissertation Director Anamaris Colberg-Poley, Professor of Integrative Systems Biology, Committee Member Robert J. Freishtat, Associate Professor of Pediatrics, Committee Member Vittorio Sartorelli, Senior Investigator, National Institutes of Health, Committee Member ii © Copyright 2015 by Jelena Perovanovic All rights reserved iii Acknowledgments I am deeply indebted to countless individuals for their support and encouragement during the past five years of graduate studies. First and foremost, I would like to express my gratitude to my mentor, Dr. Eric P. Hoffman, for his unwavering support and guidance, and keen attention to my professional development. This Dissertation would not have been possible without the critical input he provided and the engaging environment he created.
    [Show full text]
  • Deficiencies in Lamin B1 and Lamin B2 Cause Neurodevelopmental Defects and Distinct Nuclear Shape Abnormalities in Neurons
    M BoC | ARTICLE Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons Catherine Coffiniera, Hea-Jin Jungb, Chika Nobumoria, Sandy Changa, Yiping Tua, Richard H. Barnes IIa, Yuko Yoshinagac, Pieter J. de Jongc, Laurent Vergnesd, Karen Reued, Loren G. Fonga, and Stephen G. Younga,d aDepartment of Medicine and bMolecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095; cChildren’s Hospital Oakland Research Institute, Oakland, CA 94609; dDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 ABSTRACT Neuronal migration is essential for the development of the mammalian brain. Monitoring Editor Here, we document severe defects in neuronal migration and reduced numbers of neurons in Thomas Michael Magin lamin B1–deficient mice. Lamin B1 deficiency resulted in striking abnormalities in the nuclear University of Leipzig shape of cortical neurons; many neurons contained a solitary nuclear bleb and exhibited an Received: Jun 13, 2011 asymmetric distribution of lamin B2. In contrast, lamin B2 deficiency led to increased numbers Revised: Sep 9, 2011 of neurons with elongated nuclei. We used conditional alleles for Lmnb1 and Lmnb2 to create Accepted: Sep 23, 2011 forebrain-specific knockout mice. The forebrain-specificLmnb1- and Lmnb2-knockout models had a small forebrain with disorganized layering of neurons and nuclear shape abnormalities, similar to abnormalities identified in the conventional knockout mice. A more severe pheno- type, complete atrophy of the cortex, was observed in forebrain-specific Lmnb1/Lmnb2 double-knockout mice. This study demonstrates that both lamin B1 and lamin B2 are essential for brain development, with lamin B1 being required for the integrity of the nuclear lamina, and lamin B2 being important for resistance to nuclear elongation in neurons.
    [Show full text]